GSK seeks COPD approval for mepolizumab
GSK looks to build on mepolizumab’s success in asthma
X
GSK seeks COPD approval for mepolizumab
https://pharmaphorum.com/news/gsk-seeks-us-copd-licence-lung-drug-mepolizumab/
Teva
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
Copaxone first on FDA’s list for faster complex generic approvals
Teva will attempt to block generic launch in courts
Huntington’s Disease wearable gets backing from NIH
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
Teva appoints Lundbeck’s Kare Schultz as CEO
Unlike AZ’s Soriot, Schultz “couldn’t refuse” top job at Teva.
Bidders lining up for Teva women’s health unit
Allergan generics buyout left Teva with $35m debts
Roche’s Herceptin facing further biosimilar threats in US
Breast cancer blockbuster facing potential trio of US competitors.
Teva’s Cinqaero to challenge Nucala after clearing NICE
Discount swings NICE decision, drug will compete with GSK rival